ETS1 and ovarian cancer: Moreover, patients aged > 60 years (Fig. 4A), those who were postmenopausal (Fig. 4B), and those with Grade III (Fig. 4C), pT3 (Fig. 4D), CA125 (Fig. 4H), and ETS1 motif methylation (Fig. 4L) ovarian cancer showed a significant trend for poor overall survival (all P < 0.05).